Global Biotech Enterprise Account Executive

Cradle; Amsterdam; On-site; EUR 120,000 - 180,000; Full time

Benefits offered by this job

Equity stake

Competitive salary

Career progression opportunities

Job summary

Cradle in Amsterdam seeks a Global Account Executive to drive multi-million euro partnerships with leading R&D organisations in Europe. You will own key strategic accounts and collaborate with product, ML, engineering, and customer success to close high-value enterprise deals.

You bring 5+ years in B2B SaaS sales, excel at translating technical topics into business value for R&D executives, and thrive building a strong biotech/AI-for-science presence. Equity, growth, and impact await.

Qualifications

• 5+ years in B2B sales (ideally SaaS) with a proven quota attainment
• Ability to translate highly technical topics into business value for R&D stakeholders and executives
• Experience selling to large global pharma/biotech customers is a plus

Responsibilities

• Drive business development across global biotech and biopharma landscape, nurturing leads and closing high-value enterprise deals
• Own strategic accounts with focus on top global players and deliver millions in ARR
• Partner with product, ML, engineering, and customer success to shape proposals
• Surfacing customer feedback to inform product direction and roadmap priorities
• Build a strong personal brand in biotech and AI-for-science; engage with scientists and executives
• Refine playbooks and sales processes as Cradle scales its enterprise sales model

Skills

B2B sales

SaaS

Enterprise deals

Strategic accounts

Cross-functional

R&D stakeholders

Education

Advanced degree in life sciences

Job description

Cradle in Amsterdam seeks a Global Account Executive to drive multi-million euro partnerships with leading R&D organisations in Europe. You will own key strategic accounts and collaborate with product, ML, engineering, and customer success to close high-value enterprise deals.

You bring 5+ years in B2B SaaS sales, excel at translating technical topics into business value for R&D executives, and thrive building a strong biotech/AI-for-science presence. Equity, growth, and impact await.